{"nctId":"NCT00135707","briefTitle":"Combined Antioxidant and Preeclampsia Prediction Studies (CAPPS)","startDateStruct":{"date":"2003-06"},"conditions":["Preeclampsia"],"count":10154,"armGroups":[{"label":"Dietary Supplement/Vitamins","type":"EXPERIMENTAL","interventionNames":["Drug: Dietary Supplement/Vitamins"]},{"label":"Placebo for Vitamin C and Vitamin E","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo for Vitamin C and Vitamin E"]}],"interventions":[{"name":"Dietary Supplement/Vitamins","otherNames":["Ascorbic Acid and d-alpha-Tocopheryl Acetate"]},{"name":"Placebo for Vitamin C and Vitamin E","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"RCT Inclusion Criteria:\n\n* Gestational age 9 -16 weeks\n* Singleton pregnancy\n* Nulliparous\n\nObservational Inclusion Criteria:\n\n* Women randomized to the RCT\n* Gestational age 9 - 12 wks\n\nExclusion Criteria RCT and Observational:\n\n* BP \\>= 135/85\n* Proteinuria\n* History or current use of anti-hypertensive medication or diuretics\n* Use of vitamins C \\> 150 mg and/or E \\> 75 IU per day\n* Pregestational diabetes\n* Current pregnancy is a result of in vitro fertilization\n* Regular use of platelet active drugs or non-steroidal anti-inflammatory drugs (NSAIDS)\n* Known fetal abnormalities\n* Documented uterine bleeding within a week of screening\n* Uterine malformations\n* History of medical complications\n* Illicit drug or alcohol abuse during current pregnancy\n* Intent to deliver elsewhere\n* Participating in another interventional study","healthyVolunteers":true,"sex":"FEMALE","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Composite of Pregnancy-associated Hypertension and Serious Adverse Outcomes in the Mother or Fetus or Neonate","description":"Severe hypertension (blood pressure \\[BP\\]\\>= 160/110) or mild hypertension (BP\\>= 140/90) \\>= 20 weeks gestation in conjunction with one of the following: elevated liver enzymes, thrombocytopenia, elevated serum creatinine levels, eclamptic seizure, an indicated preterm birth before 32 weeks of gestation owing to hypertension-related disorders, a fetus that was small for gestational age (below 3rd percentile) adjusted for sex and race or ethnic group, fetal death after 20 weeks of gestation, or neonatal death","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"305","spread":null},{"groupId":"OG001","value":"285","spread":null}]}]}]},{"type":"PRIMARY","title":"Severe Hypertension","description":"Included here are women who had severe hypertension only and those who had severe hypertension with elevated liver enzyme levels, thrombocytopenia, elevated serum creatinine levels, eclamptic seizure, medically indicated preterm birth, fetal-growth restriction, or fetal death after 20 weeks of gestation, or neonatal death.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"210","spread":null},{"groupId":"OG001","value":"204","spread":null}]}]}]},{"type":"PRIMARY","title":"Severe or Mild Pregnancy-associated Hypertension With Elevated Liver Enzyme Levels","description":"Elevated liver enzyme levels are specified as an aspartate aminotransferase level of \\>= 100 U per liter. Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"26","spread":null},{"groupId":"OG001","value":"33","spread":null}]}]}]},{"type":"PRIMARY","title":"Severe or Mild Pregnancy-associated Hypertension With Thrombocytopenia","description":"Thrombocytopenia defined as a platelet count of \\<100,000 per cubic millimeter. Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21","spread":null},{"groupId":"OG001","value":"31","spread":null}]}]}]},{"type":"PRIMARY","title":"Severe or Mild Pregnancy-associated Hypertension With an Elevated Serum Creatinine Level","description":"Elevated serum creatinine defined as ≥1.5 mg per deciliter or 132.6 μmol per liter. Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]},{"type":"PRIMARY","title":"Severe or Mild Pregnancy-associated Hypertension With an Eclamptic Seizure","description":"Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"PRIMARY","title":"Severe or Mild Pregnancy-associated Hypertension With an Indicated Preterm Birth Before 32 Weeks of Gestation Owing to Hypertension-related Disorders","description":"Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"16","spread":null}]}]}]},{"type":"PRIMARY","title":"Severe or Mild Pregnancy-associated Hypertension With a Fetus That Was Small for Gestational Age (Below the 3rd Percentile) Adjusted for Sex and Race or Ethnic Group","description":"Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60","spread":null},{"groupId":"OG001","value":"46","spread":null}]}]}]},{"type":"PRIMARY","title":"Severe or Mild Pregnancy-associated Hypertension With a Fetal Death After 20 Weeks of Gestation or Neonatal Death","description":"Women who met more than one component of the primary outcome were counted for each component. Therefore, the number of women for all individual components combined is greater than the number of women with the primary outcome.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"12","spread":null},{"groupId":"OG001","value":"11","spread":null}]}]}]},{"type":"SECONDARY","title":"Preeclampsia (Mild, Severe, HELLP Syndrome, Eclampsia)","description":"HELLP denotes hemolytic anemia, elevated liver enzymes, and low platelet count.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"358","spread":null},{"groupId":"OG001","value":"332","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"212","spread":null},{"groupId":"OG001","value":"191","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"134","spread":null},{"groupId":"OG001","value":"129","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"4","spread":null}]}]}]},{"type":"SECONDARY","title":"Pregnancy Associated Hypertension","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1457","spread":null},{"groupId":"OG001","value":"1322","spread":null}]}]}]},{"type":"SECONDARY","title":"Medically Indicated Delivery Because of Hypertension","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"509","spread":null},{"groupId":"OG001","value":"473","spread":null}]}]}]},{"type":"SECONDARY","title":"Aspartate Aminotransferase ≥100 U/Liter","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35","spread":null},{"groupId":"OG001","value":"48","spread":null}]}]}]},{"type":"SECONDARY","title":"Creatinine ≥1.5 mg/dl (133 μmol/Liter)","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"12","spread":null}]}]}]},{"type":"SECONDARY","title":"Antepartum Bleeding","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"56","spread":null},{"groupId":"OG001","value":"46","spread":null}]}]}]},{"type":"SECONDARY","title":"Premature Rupture of Membranes","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"124","spread":null},{"groupId":"OG001","value":"129","spread":null}]}]}]},{"type":"SECONDARY","title":"Placental Abruption","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"36","spread":null}]}]}]},{"type":"SECONDARY","title":"Cesarean Delivery","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1269","spread":null},{"groupId":"OG001","value":"1224","spread":null}]}]}]},{"type":"SECONDARY","title":"Maternal Death","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Postpartum Pulmonary Edema","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3","spread":null},{"groupId":"OG001","value":"10","spread":null}]}]}]},{"type":"SECONDARY","title":"Hematocrit ≤24% With Transfusion","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"40","spread":null},{"groupId":"OG001","value":"59","spread":null}]}]}]},{"type":"SECONDARY","title":"Maternal Hospital Stay","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":null},{"groupId":"OG001","value":"2.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Gestational Age at Delivery","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"38.9","spread":"3.5"},{"groupId":"OG001","value":"38.8","spread":"3.5"}]}]}]},{"type":"SECONDARY","title":"Preterm Birth","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"513","spread":null},{"groupId":"OG001","value":"526","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"149","spread":null},{"groupId":"OG001","value":"173","spread":null}]}]}]},{"type":"SECONDARY","title":"Fetal or Neonatal Death","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"113","spread":null},{"groupId":"OG001","value":"122","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"55","spread":null},{"groupId":"OG001","value":"59","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38","spread":null},{"groupId":"OG001","value":"36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20","spread":null},{"groupId":"OG001","value":"27","spread":null}]}]}]},{"type":"SECONDARY","title":"Birth Weight","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3247","spread":"575"},{"groupId":"OG001","value":"3244","spread":"581"}]}]}]},{"type":"SECONDARY","title":"Small for Gestational Age","description":"A baby whose birth weight is less than the 3rd percentile is considered to be small for gestational age (adjusted for sex and race or ethnic group)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"133","spread":null},{"groupId":"OG001","value":"132","spread":null}]}]}]},{"type":"SECONDARY","title":"Birth Weight <2500 Grams","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"345","spread":null},{"groupId":"OG001","value":"369","spread":null}]}]}]},{"type":"SECONDARY","title":"Admission to NICU","description":"NICU denotes neonatal intensive care unit.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"577","spread":null},{"groupId":"OG001","value":"557","spread":null}]}]}]},{"type":"SECONDARY","title":"Respiratory Distress Syndrome","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"150","spread":null},{"groupId":"OG001","value":"144","spread":null}]}]}]},{"type":"SECONDARY","title":"Intraventricular Hemorrhage, Grade III or IV","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]},{"type":"SECONDARY","title":"Sepsis","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"30","spread":null},{"groupId":"OG001","value":"23","spread":null}]}]}]},{"type":"SECONDARY","title":"Necrotizing Enterocolitis","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10","spread":null},{"groupId":"OG001","value":"14","spread":null}]}]}]},{"type":"SECONDARY","title":"Retinopathy of Prematurity","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"19","spread":null},{"groupId":"OG001","value":"16","spread":null}]}]}]},{"type":"SECONDARY","title":"Apgar Score <=3 at 5 Minutes","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23","spread":null},{"groupId":"OG001","value":"27","spread":null}]}]}]},{"type":"SECONDARY","title":"Neonatal Hospital Stay","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.0","spread":null},{"groupId":"OG001","value":"2.0","spread":null}]}]}]},{"type":"POST_HOC","title":"Analysis of Primary Composite Outcome in Participants Randomized on or After the 13th Week of Pregnancy","description":"Subgroup analysis of the primary composite outcome (severe pregnancy associated hypertension or severe or mild hypertension with elevated liver-enzyme levels, thrombocytopenia, elevated serum creatinine levels, eclamptic seizure, indicated preterm birth, fetal-growth restriction or prenatal death) in participants who were randomized on or after the 13th week of pregnancy.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"161","spread":null},{"groupId":"OG001","value":"158","spread":null}]}]}]},{"type":"POST_HOC","title":"Analysis of Primary Composite Outcome in Participants Randomized Before the 13th Week of Pregnancy","description":"Subgroup analysis of the primary composite outcome (severe pregnancy associated hypertension or severe or mild hypertension with elevated liver-enzyme levels, thrombocytopenia, elevated serum creatinine levels, eclamptic seizure, indicated preterm birth, fetal-growth restriction or prenatal death) in participants who were randomized before the 13th week of pregnancy.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"144","spread":null},{"groupId":"OG001","value":"127","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":108,"n":5087},"commonTop":[]}}}